Exploratory study of relation between efficacy and serum infliximab level, and predictors of response to infliximab dose escalation in patients with crohn's disease

Trial Profile

Exploratory study of relation between efficacy and serum infliximab level, and predictors of response to infliximab dose escalation in patients with crohn's disease

Recruiting
Phase of Trial: Phase I

Latest Information Update: 31 Dec 2014

At a glance

  • Drugs Infliximab (Primary)
  • Indications Crohn's disease
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Dec 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 06 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top